Klin Farmakol Farm. 2017;31(3):23-27 | DOI: 10.36290/far.2017.034

Intrathecal drug administration in cancer patient with refractory pain

Jana Gregorová1,2,3, Petra Holečková4,5
1 Oddělení klinické farmacie, Nemocnice Na Bulovce, Praha
2 Ústav aplikované farmacie, Farmaceutická fakulta VFU, Brno
3 Ústav farmakologie 2. lékařská fakulta UK, Praha
4 Ústav radiační onkologie, Nemocnice Na Bulovce, Praha
5 1. lékařská fakulta UK, Praha

An oncological 69-year-old patient with a diagnosis of rectosigma carcinoma after successful conservative treatment of spondylitiswas treated with progression of pain that significantly restricted him not only in usual daily activities, but mainly prevented himfrom lying down. The effect of systemic administration of high doses of opioids, supplemented with non-steroidal anti-inflammatoryand co-analgesics, was not sufficient.

Keywords: opioids, refractory pain, epidural, intrathecal drug delivery, cancer patient

Received: March 22, 2018; Accepted: August 8, 2018; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregorová J, Holečková P. Intrathecal drug administration in cancer patient with refractory pain. Klin Farmakol Farm. 2017;31(3):23-27. doi: 10.36290/far.2017.034.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. http://www.who.int/cancer/palliative/painladder/en/.
    2. Smyth CE, Jarvis V, et al. Brief review: Neuraxial analgesia in refractory malignant pain. Can J Anesth/J Can Anesth. 2014; 61: 141-153. Go to original source... Go to PubMed...
    3. Pergolizzi JV, Raffa RB. The WHO Pain Ladder: Do We Need Another Step? www.practicalpainmanagement.com/issue/1401.
    4. Serlin Y, Shelef I, et al. Anatomy and physiology of the blood-brain barrier. Seminars in Cell & Developmental Biology. 2015; 38: 2-6. Go to original source... Go to PubMed...
    5. Zech DFJ, Grond S, et al. Validation of the WHO Guidelines for cancer pain relief: a 10 year prospective study. Pain. 1995; 63: 65-76. Go to original source... Go to PubMed...
    6. Deer TR, et al. Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel. Neuromodulation. 2012; 15: 436-466. Go to original source... Go to PubMed...
    7. Plas AA, Marinus J, et al. The lack of efficacy of different infusion rates of intrathecal baclofen in complex regional pain syndrome: a randomized, double-blind, crossover study. Pain Med 2011; 12: 459-465. Go to original source... Go to PubMed...
    8. Perruchoud C, Eldabe S, et al. Effects of flow rate modifications on reported analgesia and quality of life in chronic pain patients treated with continuous intratecal drug therapy. Pain Med 2011; 12: 571-576. Go to original source... Go to PubMed...
    9. Ripamonti CI, Santini D, et al. Management of cancer pain: ESMO Clinical Practice Guidelines. Annals of Oncology. 2012; 23(Suppl 7): vii139-vii154. Go to original source... Go to PubMed...
    10. Hayek SM, Deer TR, et al. Intrathecal Therapy for Cancer and Non-Cancer Pain. Pain Physician 2011; 14: 219-248. Go to original source... Go to PubMed...
    11. Kurita GP, Kaasa S, et al. Spinal opioids in adult patients with cancer pain: a systematic review: a European Palliative Care Research Collaborative (EPCRC) opioid guidelines project. Palliativ Med. 2011; 25(5): 560-577. Go to original source... Go to PubMed...
    12. Deer TR, Smith HS, et al. Comprehensive Consensus Based Guidelines on Intrathecal Drug Delivery Systems in the Treatment of Pain Caused by Cancer Pain. Pain Physician 2011; 14: E283-E312. Go to original source... Go to PubMed...
    13. Burton AW, Rajagopal R, et al. Epidural and Intrathecal Analgesia Is Effective in Treating Refractory Cancer Pain. Pain medicine. 2004; 6: 239-247. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.